Analysis of blood donors' characteristics and deferrals related to COVID-19 in Iran

被引:19
作者
Rafiee, Mohammad Hessam [1 ]
Kafiabad, Sedigheh Amini [1 ]
Maghsudlu, Mahtab [1 ]
机构
[1] High Inst Res & Educ Transfus Med, Blood Transfus Res Ctr, Tehran 146651157, Iran
关键词
COVID-19; Blood donors; Temporary deferrals; Donor selection; DONATION; SAFETY;
D O I
10.1016/j.transci.2020.103049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: With the outbreak of the coronavirus disease in 2019, called COVID-19, Iranian Blood Transfusion Organization (IBTO) implemented the new deferrals. This study analyzed the COVID-19 deferrals of blood volunteers and compared the demographics, deferrals, and the donor status during the COVID-19 outbreak in 2019. Study design and methods: Data were collected from the integrated blood donor database between Feb-Apr 2019 and 2020. Deferral reasons of COVID-19 were categorized as: those who have symptoms or live with a symptomatic family member, have direct exposure with a confirmed case, have travelled from the outbreak affected areas, and have fully recovered from confirmed COVID-19. The z-test analysis was used, and 95 % confidence intervals were calculated to compare the sample proportions. Results: The blood donations dropped to 26.09 % in 2020. The percent change of first-time blood donors, female donors, and donors within the age group of 45-54 years old was significantly greater in 2020 than the same time frame in 2019 (p < 0.05). The results showed that 0.58 % of volunteers were deferred from blood donation to avoid transmission of SARS-CoV-2. The rate of COVID-19 deferrals in all types except travelling to affected areas has increased in the second 30-day of the study (p < 0.05). Conclusion: The blood shortage that occurred during the COVID-19 outbreak was not due to increased deferral for COVID-19, but it was mostly due to a decrease in the number of volunteers who referred to BTCs.
引用
收藏
页数:6
相关论文
共 29 条
  • [1] AABB's Coronavirus Resources, UPD IMP 2019 NOV COR
  • [2] [Anonymous], 2020, IN PRESS, DOI DOI 10.1016/S2352-3026(20)30186-1
  • [3] Birjandi F, 2013, ARCH IRAN MED, V16, P657, DOI 0131611/AIM.009
  • [4] SAFETY OF BLOOD DONATIONS FOLLOWING A NATURAL DISASTER
    BUSCH, MP
    GUILTINAN, A
    SKETTINO, S
    CORDELL, R
    ZEGER, G
    KLEINMAN, S
    [J]. TRANSFUSION, 1991, 31 (08) : 719 - 723
  • [5] Coronavirus Disease 2019: Coronaviruses and Blood Safety
    Chang, Le
    Yan, Ying
    Wang, Lunan
    [J]. TRANSFUSION MEDICINE REVIEWS, 2020, 34 (02) : 75 - 80
  • [6] Cheraghali AM, 2012, IRAN J PUBLIC HEALTH, V41, P89
  • [7] CSBT, 2020, REC BLOOD EST REG NO
  • [8] European Centre for Disease prevention and Control, 2020, COR DIS 2019 COVID 1
  • [9] FDA, 2020, UPD INF BLOOD EST RE
  • [10] Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI [10.46234/ccdcw2020.032, 10.3760/cma.j.issn.0254-6450.2020.02.003]